Dr. Matías Fernández Viña will speak at the TOBI/ASIPP Congress in Las Vegas, USA.
We are pleased to announce that Dr. Matías Fernández Viña, CEO of Stem Cell Therapy Argentina, will be one of the featured speakers at the prestigious TOBI/ASIPP Congress, to be held in Las Vegas from August 21-23, 2025.
Dr. Fernández Viña, recognized for his leadership in the field of regenerative medicine and cellular therapies, will present a lecture on orthobiologic regenerative therapies of adipose tissue in the treatment of osteoarthritis of the knee. During his dissertation, Dr. Fernández Viña will share the follow-up scientific data he has collected throughout his career, demonstrating the efficacy and safety of these innovative therapies.
Osteoarthritis of the knee is a degenerative disease that affects millions of people worldwide, causing pain, stiffness and loss of joint function. Orthobiologic regenerative therapies, which use mesenchymal stem cells derived from the patient’s own adipose tissue, have shown promising results in regenerating cartilage and improving patients’ quality of life.
Dr. Fernández Viña Matias has more than 10 years of experience in regenerative treatments with adult mesenchymal cells and hyperconcentrated platelet-rich plasma. Since founding Stem Cell Therapy Argentina in 2016, he has treated more than 7,000 patients with degenerative conditions in more than 10 countries in Latin America and Africa. Its innovative and personalized approach has made a big difference compared to other centers that have wanted to copy its regenerative medicine processes and protocols, offering non-surgical and outpatient treatments but unlike the high quality due to the huge technological investment that Stem Cell Therapy Argentina has in its 6 regenerative medicine locations.
Stem Cell Therapy Argentina has positioned itself as one of the most important centers in the country and in Latin America, thanks to the arrival and treatment of a large number of patients from different regions, especially from the United States and Canada. The center has published research results in world congresses of regenerative medicine and cell therapy, demonstrating its scientific support and commitment to excellence, such as ISCT, World Stem Cell Summit, SLARD, AATD, AAOT, and ATOBA.
Don’t miss this opportunity to learn first-hand about advances in orthobiologic regenerative therapies and how they are transforming the treatment of osteoarthritis of the knee.
We look forward to seeing you in Las Vegas!
